Literature DB >> 28378566

Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.

Jie Zhang1, Huan Liu1, Bin Wei1.   

Abstract

Herpes simplex virus type 1 (HSV-1), a neurotropic member of the alphaherpes virus family, is among the most prevalent and successful human pathogens. HSV-1 can cause serious diseases at every stage of life including fatal disseminated disease in newborns, cold sores, eye disease, and fatal encephalitis in adults. HSV-1 infection can trigger rapid immune responses, and efficient inhibition and clearance of HSV-1 infection rely on both the innate and adaptive immune responses of the host. Multiple strategies have been used to restrict host innate immune responses by HSV-1 to facilitate its infection in host cells. The adaptive immunity of the host plays an important role in inhibiting HSV-1 infections. The activation and regulation of T cells are the important aspects of the adaptive immunity. They play a crucial role in host-mediated immunity and are important for clearing HSV-1. In this review, we examine the findings on T cell immune responses during HSV-1 infection, which hold promise in the design of new vaccine candidates for HSV-1.

Entities:  

Keywords:  Herpes simplex virus type 1; Adaptive immunity; T cells; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28378566      PMCID: PMC5394093          DOI: 10.1631/jzus.B1600460

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  134 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

Review 2.  Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.

Authors:  F Aloisi; F Ria; L Adorini
Journal:  Immunol Today       Date:  2000-03

Review 3.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

4.  Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia.

Authors:  S Noisakran; D J Carr
Journal:  J Neuroimmunol       Date:  1999-03-01       Impact factor: 3.478

5.  Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan.

Authors:  M Hashido; T Kawana; Y Matsunaga; S Inouye
Journal:  Microbiol Immunol       Date:  1999       Impact factor: 1.955

6.  Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.

Authors:  A Cerwenka; T M Morgan; R W Dutton
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 7.  Prospects for control of herpes simplex virus disease through immunization.

Authors:  L R Stanberry; A L Cunningham; A Mindel; L L Scott; S L Spruance; F Y Aoki; C J Lacey
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

8.  DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.

Authors:  J Sin; J J Kim; C Pachuk; C Satishchandran; D B Weiner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system.

Authors:  P Kodukula; T Liu; N V Rooijen; M J Jager; R L Hendricks
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

10.  CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; X Chen; D J Fink; R L Hendricks
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  14 in total

1.  Changes in peripheral blood inflammatory factors (TNF-α and IL-6) and intestinal flora in AIDS and HIV-positive individuals.

Authors:  Jing Lu; Sai-Sai Ma; Wei-Ying Zhang; Jian-Ping Duan
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

Review 2.  The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics.

Authors:  Kimberly Ann Rivera-Caraballo; Mitra Nair; Tae Jin Lee; Balveen Kaur; Ji Young Yoo
Journal:  Mol Ther Oncolytics       Date:  2022-06-06       Impact factor: 6.311

3.  Herpes Simplex Keratitis in Patients with SARS-CoV-2 Infection: A Series of Five Cases.

Authors:  Nora Majtanova; Petra Kriskova; Petra Keri; Zlatica Fellner; Juraj Majtan; Petr Kolar
Journal:  Medicina (Kaunas)       Date:  2021-04-24       Impact factor: 2.430

4.  Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients.

Authors:  Francesca La Rosa; Simone Agostini; Anna Bianchi; Raffaello Nemni; Federica Piancone; Ivana Marventano; Roberta Mancuso; Marina Saresella; Mario Clerici
Journal:  J Transl Med       Date:  2019-08-27       Impact factor: 5.531

Review 5.  Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators.

Authors:  Li Wang; Runbiao Wang; Chuyang Xu; Hongyan Zhou
Journal:  Front Immunol       Date:  2020-05-13       Impact factor: 7.561

6.  Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction.

Authors:  Jessica R Doll; Kasper Hoebe; Richard L Thompson; Nancy M Sawtell
Journal:  PLoS Pathog       Date:  2020-03-05       Impact factor: 6.823

Review 7.  Disrupting Neurons and Glial Cells Oneness in the Brain-The Possible Causal Role of Herpes Simplex Virus Type 1 (HSV-1) in Alzheimer's Disease.

Authors:  Matylda Barbara Mielcarska; Katarzyna Skowrońska; Zbigniew Wyżewski; Felix Ngosa Toka
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

Review 8.  Immune Response to Herpes Simplex Virus Infection and Vaccine Development.

Authors:  Anthony C Ike; Chisom J Onu; Chukwuebuka M Ononugbo; Eleazar E Reward; Sophia O Muo
Journal:  Vaccines (Basel)       Date:  2020-06-12

Review 9.  Ocular transmissibility of COVID-19: possibilities and perspectives.

Authors:  Gavin Davis; Kin Li; Finosh G Thankam; Daniel R Wilson; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2022-01-23       Impact factor: 3.842

10.  Network and co-expression analysis of airway smooth muscle cell transcriptome delineates potential gene signatures in asthma.

Authors:  Priyanka Banerjee; Premanand Balraj; Nilesh Sudhakar Ambhore; Sarah A Wicher; Rodney D Britt; Christina M Pabelick; Y S Prakash; Venkatachalem Sathish
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.